Skip to main content
Divi's Laboratories Ltd. logo

Divi's Laboratories Ltd. — Investor Relations & Filings

Ticker · DIVISLAB ISIN · INE361B01024 LEI · 335800C1DHFG1C9T1M03 BSE.NS Manufacturing
Open in API
Filings indexed 572 across all filing types
Latest filing 2026-05-15 Report Publication Anno…
Country IN India
Listing BSE.NS DIVISLAB

About Divi's Laboratories Ltd.

https://www.divislabs.com/

Divi's Laboratories Ltd. is a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and Intermediates, specializing in Contract Research and Manufacturing Services (CRAMS) for the global pharmaceutical industry. The company operates through two primary business segments: Generic APIs and Custom Synthesis of APIs and intermediates for discovery-marketed drugs. Its product portfolio includes a wide range of therapeutic areas, with significant market leadership in products such as Naproxen, Dextromethorphan, and Gabapentin. Additionally, the company produces nutraceutical ingredients, including a comprehensive range of carotenoids. Divi's maintains large-scale manufacturing facilities compliant with international regulatory standards, including the USFDA and EU GMP. The organization focuses on process chemistry and efficient large-scale production to support major global pharmaceutical companies in drug development and commercialization.

Recent filings

Filing Released Lang Actions
Intimation of schedule of earnings conference call for the quarter and year ended March 31, 2026 to be held on May 23, 2026 at 14:30 Hrs (IST).
Report Publication Announcement Classification · 90% confidence The document is a notice under SEBI Regulation 30 announcing (1) the release date of audited financial results for Q4FY26 (March 31, 2026) on May 23, 2026 and (2) the schedule of the related earnings conference call. It contains no actual financial data, highlights, or call transcript, only the timing and dial-in details. This fits the definition of a Report Publication Announcement rather than an Earnings Release, Call Transcript, or Interim/Quarterly Report itself.
2026-05-15 English
Analysts/Institutional Investor Meet/Con. Call Updates
Report Publication Announcement Classification · 90% confidence The document is a notice under SEBI LODR Regulation 30 announcing the schedule of the Q4 FY26 earnings conference call and the date when audited financial results will be released. It contains no actual financial data or results—only a timing/notice of report release and call details. This matches a Report Publication Announcement, not an earnings release or transcript.
2026-05-15 English
Copy of Newspaper Publication regarding loss of Share Certificate.
Regulatory Filings Classification · 82% confidence The document is a notice from Divi’s Laboratories to the stock exchanges enclosing copies of a newspaper publication regarding a shareholder’s lost share certificate and inviting claims. It contains no financial statements, report attachments, or executive certifications beyond compliance disclosure. This is a routine regulatory compliance announcement that does not fit any specialized category, so it falls under Regulatory Filings (RNS).
2026-05-15 English
Copy of Newspaper Publication
Regulatory Filings Classification · 85% confidence The document is a statutory notice filed with stock exchanges enclosing newspaper publications about a shareholder’s lost share certificates and inviting claims. It is a routine regulatory announcement rather than an AGM notice, financial report, management change, dividend notice, or capital transaction. It contains no financial statements or substantive data, nor does it solicit votes. Therefore, it falls under general regulatory filings.
2026-05-15 English
Divis Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2026 ,inter alia, to consider and approve audited standalone and consolidated ...
Regulatory Filings Classification · 85% confidence The document is a formal notice to stock exchanges under SEBI LODR Regulation 29 announcing a Board of Directors meeting date to consider financial results and recommend dividends. It does not contain actual financial results or management changes, nor is it a transcript or filing of results. It is a regulatory compliance announcement (board meeting intimation). Therefore it falls under the general Regulatory Filings category.
2026-05-14 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2026-04-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.